Select Medical Q2 EPS $0.61 (+44% YoY), revenue up 5.7%; declares $0.125 dividend

SELECT MEDICAL HOLDINGS CORP

2023-Q2 EPS reported $1.17 revenue$3,339,508,000

Q2 revenue $1,674.5M (+5.7% YoY); net income $91.9M (+38.6% YoY); Adjusted EBITDA $219.5M (+21.3% YoY).
Critical illness recovery hospital segment Adjusted EBITDA surged 227% to $65.5M; margin 11.4% vs 3.7%.
Board declared $0.125/share cash dividend, payable Sep 1, 2023 to holders of record Aug 15.
FY2023 outlook: revenue $6.55-6.7B, Adjusted EBITDA $795-825M, EPS $1.77-1.94, adjusted EPS $1.86-2.03.
No shares repurchased in H1 2023; $1.0B buyback program expires Dec 31, 2023.

item 2.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SELECT MEDICAL HOLDINGS CORP reported second quarter ended June 30, 2023 results: revenue $1,674.5 million, net income $91.9 million, EPS $0.61.

Period: second quarter ended June 30, 2023
Revenue: $1,674.5 million
Net income: $91.9 million
EPS: $0.61
Result: reported results

Exact text from the filing

For the second quarter ended June 30, 2023, revenue increased 5.7% to $1,674.5 million, compared to $1,584.7 million for the same quarter, prior year.

View on SEC.gov

Browse all earnings releases →

SELECT MEDICAL HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0001104659-23-087347

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.